(Q50941188)

English

Renal cancer.

scientific article published on 25 August 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318520%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Renal cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318520%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Umberto Capitanio

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318520%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Francesco Montorsi

2

object named as

Francesco Montorsi

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318520%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

0 references

publication date

25 August 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318520%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318520%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

387

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318520%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

10021

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318520%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

894-906

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318520%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

New modalities for evaluation and surveillance of complex renal cysts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Not all renal cysts are created equal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The changing pattern of kidney cancer incidence and mortality in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Re: Rising incidence of small renal masses: a need to reassess treatment effect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rising incidence of small renal masses: a need to reassess treatment effect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Are increasing 5-year survival rates evidence of success against cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Smoking, environmental tobacco smoke, and risk of renal cell cancer: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Polymorphisms in genes of the renin-angiotensin-aldosterone system and renal cell cancer risk: interplay with hypertension and intakes of sodium, potassium and fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

History of treated hypertension and diabetes mellitus and risk of renal cell cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertension, antihypertensive therapy and renal-cell cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Obesity and renal cancer: Role of adipokines in the tumor-immune system conflict

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective study of alcohol consumption and renal cell carcinoma risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Meat and fish consumption and the risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Distribution of metastatic sites in renal cell carcinoma: a population-based analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

PBRM1 and BAP1 as novel targets for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive molecular characterization of clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

VHL, the story of a tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hereditary papillary renal carcinoma type I

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Birt-Hogg-Dubé syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Everolimus for renal angiomyolipoma in tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Paraneoplastic syndromes in patients with urological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Associations between presenting symptoms, clinicopathological parameters, and prognosis in a contemporary series of patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent advances in imaging cancer of the kidney and urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

EAU guidelines on renal cell carcinoma: 2014 update.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Grade heterogeneity in small renal masses: potential implications for renal mass biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale for percutaneous biopsy and histologic characterisation of renal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment management of small renal masses in the 21st century: a paradigm shift.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Is anatomic complexity associated with renal tumor growth kinetics under active surveillance?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Active surveillance as the preferred management option for small renal masses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed intervention of sporadic renal masses undergoing active surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Active surveillance of small renal masses: progression patterns of early stage kidney cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The cryobiology of cryosurgical injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Kidney cancer, version 3.2015.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in the surgical management of localized renal masses: thermal ablation, partial and radical nephrectomy in the USA, 1998-2008.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Focal therapy for treatment of the small renal mass: dealer's choice or a therapeutic gamble?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgically induced chronic kidney disease may be associated with a lower risk of progression and mortality than medical chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Multi-institutional validation of a new renal cancer-specific survival nomogram

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical versus partial nephrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Can emerging level 1 evidence "discourage" elective nephron-sparing surgery for small renal tumors?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Partial nephrectomy in the setting of metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytoreductive Partial Nephrectomy Does Not Undermine Cancer Control in Metastatic Renal Cell Carcinoma: A Population-Based Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal Ischemia and Function After Partial Nephrectomy: A Collaborative Review of the Literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance of the human kidney to isolated controlled ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional recovery after partial nephrectomy: effects of volume loss and ischemic injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Ischemic renal damage after nephron-sparing surgery in patients with normal contralateral kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Partial nephrectomy for small renal masses: an emerging quality of care concern?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Contemporary use of partial nephrectomy at a tertiary care center in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Kidney tumor location measurement using the C index method

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The Effect of the Diffusion of the Surgical Robot on the Hospital-level Utilization of Partial Nephrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of perioperative outcomes between robotic and laparoscopic partial nephrectomy: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Laparoscopic versus open radical nephrectomy for large renal tumors: a long-term prospective comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Robotic radical nephrectomy for renal cell carcinoma: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymph node dissection in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility of sentinel node detection in renal cell carcinoma: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraoperative sentinel node identification and sampling in clinically node-negative renal cell carcinoma: initial experience in 20 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

SEOM clinical guidelines for the treatment of renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with interferon alfa-2a and interleukin-2 for the treatment of metastatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of temsirolimus and bevacizumab versus interferon alfa and bevacizumab in metastatic renal cell carcinoma: INTORACT trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pazopanib versus sunitinib in metastatic renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Overall survival in renal-cell carcinoma with pazopanib versus sunitinib

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of pazopanib versus sunitinib for renal cancer in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Current practices in the management of adverse events associated with targeted therapies for advanced renal cell carcinoma: a national survey of oncologists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy for renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequencing systemic therapies for metastatic kidney cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tivozanib for the treatment of renal cell carcinoma: results and implications of the TIVO-1 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cabozantinib as a novel therapy for renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sirolimus in metatastic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma: a multicentric randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Kidney cancer management in 2004: an update for the practicing general urologist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgery for renal cell carcinoma metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Local treatments for metastases of renal cell carcinoma: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900046-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy for advanced renal cell cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001425.PUB2

Identifiers

10.1016/S0140-6736(15)00046-X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318520%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318520%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50941188&oldid=2040522534"